高级检索
武丽, 黄千峰, 纪存委, 吕霄, 缪华章, 高爽, 刘婷艳, 夏建红. 宫颈癌不同初筛方法检出率及随访质量评价[J]. 中国公共卫生, 2018, 34(10): 1380-1382. DOI: 10.11847/zgggws1117108
引用本文: 武丽, 黄千峰, 纪存委, 吕霄, 缪华章, 高爽, 刘婷艳, 夏建红. 宫颈癌不同初筛方法检出率及随访质量评价[J]. 中国公共卫生, 2018, 34(10): 1380-1382. DOI: 10.11847/zgggws1117108
Li WU, Qian-feng HUANG, Cun-wei JI, . Evaluation on detection rate and follow-up quality of different cervical cancer screening methods[J]. Chinese Journal of Public Health, 2018, 34(10): 1380-1382. DOI: 10.11847/zgggws1117108
Citation: Li WU, Qian-feng HUANG, Cun-wei JI, . Evaluation on detection rate and follow-up quality of different cervical cancer screening methods[J]. Chinese Journal of Public Health, 2018, 34(10): 1380-1382. DOI: 10.11847/zgggws1117108

宫颈癌不同初筛方法检出率及随访质量评价

Evaluation on detection rate and follow-up quality of different cervical cancer screening methods

  • 摘要:
      目的  评价液基细胞学检查(TCT)与人乳头瘤病毒(HPV)检测分别作为初筛方法在广东省宫颈癌筛查中的应用效果。
      方法  于2014 — 2015年对广东省2个项目县35~64岁的39 974名妇女采用TCT检测方法进行初筛,对4个项目县的40 087名妇女采用HPV检测方法进行初筛,评估分析2种初筛方法的宫颈癌及癌前病变检出率、阴道镜随访率、组织病理学检查随访率以及HPV初筛方法的细胞学随访率等指标。
      结果  宫颈癌监测试点项目中宫颈癌(45.03/10万)、癌前病变(798.02/10万)、宫颈癌及癌前病变检出率(843.05/10万)高于HPV试点项目中宫颈癌(19.96/10万)、癌前病变(162.15/10万)、宫颈癌及癌前病变的检出率(182.10/10万)。HPV检测项目中,细胞学检查和阴道镜检查随访率较低,分别只有55.04 %和58.46 %。
      结论  采用TCT做初筛的地区在检出率和筛查质量方面都远高于采用HPV做初筛的地区,应加强HPV试点地区阳性病例的随访,提高细胞学检查和阴道镜检查的随访率,从而提高宫颈癌和癌前病变的检出率。

     

    Abstract:
      Objective  To assess the application effect of ThinPrep cytology test (TCT) and human papillomavirus (HPV)-DNA detection in cervical cancer screening.
      Methods  A total of 39 974 women aged 35 – 64 years were screened for cervical cancer with TCT in two counties and another 40 087 women of same ages with HPV test in four counties in Guangdong province. Then the screening efficiency of the two methods were evaluated and compared using detection rate of cervical cancer and precancerous lesion, follow-up rate for colposcopy, histopathological examination, and cytologic examination.
      Results  The overall detection rate of cervical cancer and precancerous lesion was 843.05/100 000 (45.03/100 000 for cervical cancer and 798.02/100 000 for precancerous lesion) for TCT and higher than that (182.10/100 000) of HPV test (19.96/100 000 for cervical cancer and 162.15/100 000 for precancerous lesion). For the screening with HPV test, the follow-up rate of cytologic examination and colposcopy were only 55.04% and 58.46%, and both the rate were at a relative low level.
      Conclusion  The detection rate and screening quality of TCT are far higher than those of HPV test. The results suggest that follow-up for cytologic examination and colposcopy should be enhanced among the women positive to HPV test to increase the detection rate of cervical cancer and precancerous lesion in the women.

     

/

返回文章
返回